Aspiro Co-founders Leading $3.8M NIH Study on Early Detection of COPD
Tucson, Arizona / August 18, 2025 —Aspiro Therapeutics is proud to share that two of our co-founders, Dr. Stefano Guerra and Dr. Julie Ledford, are contributing to a newly awarded $3.8 million grant from the National Institute of Allergy and Infectious Diseases (NIAID) focused on CC16 and its role in early chronic obstructive pulmonary disease […]